Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Natural Alternatives v. Iancu, No. 17-1963 (Fed. Cir. Oct. 1, 2018)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 17-1963
Decided
October 1, 2018
Judge
Prost, C.J.
Document
Nonprecedential Opinion
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

NATURAL ALTERNATIVES INTERNATIONAL,

INC.,

Appellant

v.

ANDREI IANCU, UNDER SECRETARY OF

COMMERCE FOR INTELLECTUAL PROPERTY

AND DIRECTOR OF THE UNITED STATES

PATENT AND TRADEMARK OFFICE,

Intervenor

2017-1963

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. 95/002,048.

Decided: October 1, 2018

SCOTT A. M. CHAMBERS, Porzio, Bromberg & Newman, PC, Washington, DC, argued for appellant. Also represented by RICHARD J. OPARIL, KEVIN M. BELL, BILLY DELL CHISM; MATTHEW ZAPADKA, Bass, Berry & Sims, PLC, Washington, DC. MARY L. KELLY, Office of the Solicitor, United States

22 NATURAL ALTERNATIVES v. IANCU

Patent and Trademark Office, Alexandria, VA, argued for intervenor. Also represented by THOMAS W. KRAUSE, ROBERT J. MCMANUS, AMY J. NELSON.

Before PROST, Chief Judge, MOORE and REYNA,

Circuit Judges.

Woodbolt Distributors, LLC (“Woodbolt”) requested that the United States Patent and Trademark Office (“PTO”) reexamine U.S. Patent No. 8,129,422 (“the ʼ422 patent”) owned by Natural Alternatives International, Inc. (“NAI”). The PTO ordered inter partes reexamination, and the examiner rejected the challenged claims as anticipated by or obvious over cited prior art, including a parent of the reexamined patent. NAI appeals the Patent Trial and Appeal Board’s (“Board”) final determination affirming the examiner’s rejections and its subsequent denial of NAI’s request for rehearing.

The ʼ422 patent issued from the seventh U.S. application in a chain of eight U.S. applications generally directed to increasing athletes’ endurance. This opinion addresses NAI’s priority challenge as to the ʼ422 patent. Our companion opinion, Natural Alternatives International, Inc. v. Matal, No. 17-1962, addressed NAI’s priority challenge as to the patent issuing from the eighth application—U.S. Patent No. 8,067,381 (“the ʼ381 patent”).

Because the facts and procedural history in the two cases are substantially identical, we do not repeat our discussion of those topics here. Regarding the merits of this appeal, we affirm the Board’s final determination and its denial of NAI’s request for rehearing for the reasons stated in our companion opinion.

AFFIRMED

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Natural Alternatives v. Iancu, No. 17-1963 (Fed. Cir. Oct. 1, 2018).

Record ID
CAFC-17-1963-20181001
Permalink
https://patentcasewatch.com/opinions/CAFC-17-1963-20181001

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.